Ametek Inc

AMETEK, Inc. has completed its all-cash acquisition of Indicor Instrumentation, a portfolio of instrumentation businesses from Indicor, LLC, for $5.0 billion. The acquired businesses, which design and manufacture mission-critical solutions for industrial and scientific applications, will join AMETEK's Electronic Instruments Group and Electromechanical Group. Indicor Instrumentation is expected to contribute approximately $350 million to AMETEK's 2026 sales and be modestly accretive to adjusted earnings. AMETEK's Chairman and CEO, David A. Zapico, said the acquisition is highly strategic and an excellent fit with the company's portfolio.

AMETEK reported second quarter results that beat analyst estimates, with revenue of $2.04 billion versus expectations of $1.96 billion and adjusted EPS of $2.09 versus $1.99. Management raised full-year adjusted EPS guidance to $8.25 at the midpoint, a 2.6% increase. During the earnings call, analysts focused on end-market strength, backlog quality, order sustainability, outperforming segments, and margin drivers. CEO David Zapico highlighted diversified growth across semiconductor, aerospace, and MedTech, with approximately 80% of backlog expected to ship within 12 months.

AMETEK declared a regular third-quarter dividend of $0.34 per share and issued updated guidance alongside fresh quarterly results. The announcement comes as shares trade at $256.30, with a 30-day return of 9.54% and a year-to-date return of 22.55%. One analyst narrative estimates a fair value of $265.33, implying the stock is about 3.4% undervalued, though its price-to-earnings ratio of 37.3 times sits above a fair ratio of 26.8 times.

AMETEK Inc. reported record second-quarter sales of $2.04 billion, up 15% year-over-year, with organic sales growth of 10%. Orders surged 28% to a record $2.3 billion, driving backlog to an all-time high of $4.11 billion. Operating income rose 18% to a record $544 million, and core operating margins expanded 110 basis points to 27.1%. Diluted earnings per share reached a record $2.09, up 17%, while free cash flow jumped 37% to $452 million. The company raised its full-year 2026 sales and earnings guidance, citing strong first-half performance and a positive outlook tied to multi-year infrastructure investments.

Component makers tied to the humanoid robotics supply chain rallied sharply on Tuesday as investors sought out specialist suppliers. Sensor makers Ouster, Cognex, and Allegro Microsystems closed up 15.6%, 5.9%, and 4.9% respectively, while edge AI vision processor maker Ambarella surged 28%. Motor makers like Nidec, RBC Bearings, Regal Beloit, and Ametek closed between 1% and 8% higher, with Regal Beloit gaining 8.3% after Kerrisdale Capital disclosed a long position citing the physical AI angle. AI brain maker NVIDIA gained 2.6%, battery maker Enersys rose 4.3%, and power electronics names such as Wolfspeed surged 9%. The moves highlight that component suppliers sell into multiple robot OEMs simultaneously, meaning any broad acceleration in humanoid build rates lifts the entire component tier. However, Reuters reported on June 29 that doubts are creeping into the broader AI trade, with a Bank for International Settlements warning that AI and automation asset valuations may be overextended, a caution directly relevant to high-multiple humanoid component names.

AMETEK stock jumped 5.1% this week after reporting record first-quarter orders of $2.2 billion, up 23% year-over-year, and raising its full-year guidance. The company's backlog reached a record $3.87 billion, driven by strong demand in defense, power, and semiconductor segments, while its operating margin of 25.9% comfortably exceeds the S&P 500 median of 18.4%. Despite this operational strength, the stock trades at a price-to-earnings ratio of 35.6 and exhibits a five-year correlation of 0.67 with the S&P 500, meaning a large share of its performance is tied to broader market forces. On up days for the index, AMETEK captures about 92% of the gain, and on down days it absorbs roughly 80% of the loss, offering a slightly softer landing but not keeping pace on the best days. Analysts caution that sustaining momentum may be challenging against tough second-half comparisons and ongoing geopolitical uncertainty.

Zacks Investment Research identifies DuPont de Nemours, Proto Labs, AMETEK, and ATI as compelling 3D printing stocks for long-term returns. DuPont strengthened its medical additive manufacturing capabilities through the 2023 acquisition of Spectrum Plastics Group, which uses proprietary processes like Projection Micro Stereolithography and Silicone 3D Printing. Proto Labs, which has manufactured over 700 million parts for more than 300,000 customers, launched an AI-enabled manufacturing platform called ProDesk in February 2026 to accelerate prototyping and production. AMETEK produces high-performance metal powders for additive manufacturing and expanded its precision scanning portfolio with the July 2025 acquisition of Faro Technologies. ATI offers end-to-end additive manufacturing capabilities from metal powder to finished parts and recently commissioned a state-of-the-art facility combining design, printing, heat treating, machining, and inspection for aerospace, defense, and space applications.